Td Asset Management Inc Avidity Biosciences, Inc. Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

A detailed history of Td Asset Management Inc transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 434,972 shares of RNA stock, worth $18 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
434,972
Previous 513,338 15.27%
Holding current value
$18 Million
Previous $21 Million 4.73%
% of portfolio
0.02%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$37.21 - $48.14 $2.92 Million - $3.77 Million
-78,366 Reduced 15.27%
434,972 $20 Million
Q2 2024

Aug 02, 2024
BUY
$22.73 - $40.85 $6.82 Million - $12.3 Million
300,054 Added 140.68%
513,338 $21 Million
Q1 2024

May 08, 2024
SELL
$9.16 - $25.52 $498,743 - $1.39 Million
-54,448 Reduced 20.34%
213,284 $5.44 Million
Q3 2023

Oct 27, 2023
BUY
$6.3 - $11.35 $843,355 - $1.52 Million
133,866 Added 100.0%
267,732 $1.71 Million
Q2 2023

Aug 09, 2023
SELL
$10.62 - $17.34 $198,615 - $324,292
-18,702 Reduced 12.26%
133,866 $1.48 Million
Q1 2023

May 10, 2023
SELL
$15.35 - $25.65 $181,851 - $303,875
-11,847 Reduced 7.21%
152,568 $2.34 Million
Q4 2022

Feb 06, 2023
BUY
$10.06 - $22.66 $313,308 - $705,723
31,144 Added 23.37%
164,415 $3.65 Million
Q3 2022

Nov 07, 2022
BUY
$15.46 - $23.43 $12,368 - $18,744
800 Added 0.6%
133,271 $2.23 Million
Q2 2022

Aug 04, 2022
SELL
$11.18 - $20.5 $118,675 - $217,607
-10,615 Reduced 7.42%
132,471 $1.93 Million
Q1 2022

May 10, 2022
SELL
$14.2 - $23.78 $74,663 - $125,035
-5,258 Reduced 3.54%
143,086 $2.64 Million
Q4 2021

Feb 10, 2022
BUY
$20.4 - $28.66 $913,287 - $1.28 Million
44,769 Added 43.22%
148,344 $3.53 Million
Q3 2021

Nov 09, 2021
BUY
$18.16 - $25.21 $1.37 Million - $1.91 Million
75,627 Added 270.6%
103,575 $2.55 Million
Q1 2021

May 14, 2021
BUY
$20.28 - $28.15 $96,106 - $133,402
4,739 Added 20.42%
27,948 $610,000
Q4 2020

Feb 16, 2021
BUY
$24.73 - $35.12 $39,568 - $56,191
1,600 Added 7.4%
23,209 $592,000
Q3 2020

Nov 10, 2020
BUY
$23.35 - $35.94 $30,355 - $46,722
1,300 Added 6.4%
21,609 $608,000
Q2 2020

Aug 13, 2020
BUY
$26.62 - $31.5 $540,625 - $639,733
20,309 New
20,309 $574,000

Others Institutions Holding RNA

# of Institutions
256
Shares Held
107M
Call Options Held
224K
Put Options Held
161K
View Full List

About Avidity Biosciences, Inc.

RNA Quotes by TradingView
  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $2.15B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email